Drug Shortage Report for VAQTA

Last updated on 2017-08-03 History
Report ID 6249
Drug Identification Number 02229702
Brand name VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size vial (fiole)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-06-19
Estimated end date 2017-08-31
Actual end date 2017-08-02
Shortage status Resolved
Updated date 2017-08-03
Company comments Limited Quantities available / Quantités limitées disponibles
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-08-03 English Compare
v13 2017-08-02 French Compare
v12 2017-08-02 English Compare
v11 2017-07-10 English Compare
v10 2017-06-20 English Compare
v9 2017-06-19 English Compare
v8 2017-06-19 English Compare
v7 2017-05-24 English Compare
v6 2017-05-05 English Compare
v5 2017-04-11 French Compare
v4 2017-04-10 English Compare
v3 2017-04-10 English Compare
v2 2017-04-10 French Compare
v1 2017-04-10 English Compare

Showing 1 to 14 of 14